Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2006 4
2007 1
2008 8
2009 2
2010 1
2011 3
2012 13
2013 11
2014 19
2015 17
2016 20
2017 22
2018 24
2019 19
2020 23
2021 20
2022 19
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Bakris GL, et al. JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081. JAMA. 2015. PMID: 26325557 Clinical Trial.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
Peptide Stapling Applied to Antimicrobial Peptides.
Lourenço ALP, Rios TB, da Silva ÁP, Franco OL, Ramada MHS. Lourenço ALP, et al. Antibiotics (Basel). 2023 Sep 2;12(9):1400. doi: 10.3390/antibiotics12091400. Antibiotics (Basel). 2023. PMID: 37760697 Free PMC article. Review.
Invasive Plants: Turning Enemies into Value.
Máximo P, Ferreira LM, Branco PS, Lourenço A. Máximo P, et al. Among authors: lourenco a. Molecules. 2020 Aug 1;25(15):3529. doi: 10.3390/molecules25153529. Molecules. 2020. PMID: 32752287 Free PMC article. Review.
ACR Appropriateness Criteria® Breast Pain.
Expert Panel on Breast Imaging:; Jokich PM, Bailey L, D'Orsi C, Green ED, Holbrook AI, Lee SJ, Lourenco AP, Mainiero MB, Moy L, Sepulveda KA, Slanetz PJ, Trikha S, Yepes MM, Newell MS. Expert Panel on Breast Imaging:, et al. Among authors: lourenco ap. J Am Coll Radiol. 2017 May;14(5S):S25-S33. doi: 10.1016/j.jacr.2017.01.028. J Am Coll Radiol. 2017. PMID: 28473081 Review.
ACR Appropriateness Criteria® Palpable Breast Masses.
Expert Panel on Breast Imaging:; Moy L, Heller SL, Bailey L, D'Orsi C, DiFlorio RM, Green ED, Holbrook AI, Lee SJ, Lourenco AP, Mainiero MB, Sepulveda KA, Slanetz PJ, Trikha S, Yepes MM, Newell MS. Expert Panel on Breast Imaging:, et al. Among authors: lourenco ap. J Am Coll Radiol. 2017 May;14(5S):S203-S224. doi: 10.1016/j.jacr.2017.02.033. J Am Coll Radiol. 2017. PMID: 28473077 Review.
ACR Appropriateness Criteria® Palpable Breast Masses: 2022 Update.
Expert Panel on Breast Imaging; Klein KA, Kocher M, Lourenco AP, Niell BL, Bennett DL, Chetlen A, Freer P, Ivansco LK, Jochelson MS, Kremer ME, Malak SF, McCrary M, Mehta TS, Neal CH, Porpiglia A, Ulaner GA, Moy L. Expert Panel on Breast Imaging, et al. Among authors: lourenco ap. J Am Coll Radiol. 2023 May;20(5S):S146-S163. doi: 10.1016/j.jacr.2023.02.013. J Am Coll Radiol. 2023. PMID: 37236740 Review.
ACR Appropriateness Criteria® Evaluation of Nipple Discharge.
Expert Panel on Breast Imaging:; Lee SJ, Trikha S, Moy L, Baron P, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lewin AA, Lourenco AP, Niell BL, Slanetz PJ, Stuckey AR, Vincoff NS, Weinstein SP, Yepes MM, Newell MS. Expert Panel on Breast Imaging:, et al. Among authors: lourenco ap. J Am Coll Radiol. 2017 May;14(5S):S138-S153. doi: 10.1016/j.jacr.2017.01.030. J Am Coll Radiol. 2017. PMID: 28473070 Review.
225 results